Anti-obesity and Anti-diabetic Effect of Ursolic Acid against Streptozotocin/High Fat Induced Obese in Diabetic Rats

J Oleo Sci. 2022 Feb 3;71(2):289-300. doi: 10.5650/jos.ess21258. Epub 2022 Jan 14.

Abstract

Obesity is occurring due to continue taken high fat diet; this is the fast-growing problem reaching epidemic proportion globally. Ursolic acid altered the abnormal glucose metabolism in diabetic rats. In this experimental protocol, we examine ursolic acid (UA) anti-obesity effect against streptozotocin (STZ) and high-fat diet-induced obesity in rats. Orally administered the ursolic acid (2.5, 5 and 10 mg/kg) dose to the hyperglycemic rats for 8 weeks and estimated the blood glucose level at different time intervals. Biochemical, hepatic, lipid, renal and antioxidant parameters were estimated. Traf-4, Mapk-8, Traf-6 and genes such as Ins-1, ngn-3 and Pdx-1 mRNA expression were estimated using qRT-PCR to scrutinize the molecular mechanism in MAPK downstream JNK cascade and insulin pathway signalling pathways. Ursolic acid significantly (p<0.001) down-regulated the blood glucose level at dose dependent manner. Its also reduced the plasma insulin level, non-essential fatty acid and increased the level of adiponectin as compared to obese control group rats. Ursolic acid treated group rats reduced the level of total cholesterol and triglycerides. Ursolic-acid-treated rats have been shown to decrease oxidative stress in pancreatic tissue by restoring the free radical effect of scavenging, suppress the Traf-6, Mapk-8 and Traf-4 mRNA expression, enhance the expression of Pdx-1, Ins-1 and Ngn-3 and ensure the regeneration of pancreas β cells and therefore pancreas insulin. The current result suggested the anti-obese effect of ursolic acid against high fat diet (HFD) induced obese rats via alteration of insulin and JNK signaling pathway.

Keywords: JNK pathway; blood glucose level; insulin; obesity; ursolic acid.

MeSH terms

  • Administration, Oral
  • Animals
  • Anti-Obesity Agents*
  • Antioxidants
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / etiology
  • Diabetes Mellitus, Experimental / metabolism
  • Diet, High-Fat / adverse effects*
  • Dose-Response Relationship, Drug
  • Glucose / metabolism
  • Hypoglycemic Agents*
  • Insulin / metabolism*
  • Lipid Metabolism / drug effects
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology
  • Mitogen-Activated Protein Kinases / metabolism
  • Obesity / drug therapy*
  • Obesity / etiology
  • Obesity / metabolism
  • Oxidative Stress / drug effects
  • Rats
  • Rats, Wistar
  • Streptozocin / adverse effects
  • Triterpenes / administration & dosage*
  • Triterpenes / pharmacology*
  • Ursolic Acid

Substances

  • Anti-Obesity Agents
  • Antioxidants
  • Hypoglycemic Agents
  • Insulin
  • Triterpenes
  • Streptozocin
  • Mitogen-Activated Protein Kinases
  • Glucose